Intramyocardial Bridging: An Overlooked Cause of Atypical Chest Pain

Intramyocardial bridging (IMB) is a congenital anomaly characterized by the tunneling of a coronary artery segment through the myocardium, potentially leading to serious cardiac complications, such as myocardial ischemia, infarction, and sudden death, challenging the traditional view of it being ben...

Full description

Saved in:
Bibliographic Details
Published in:Curēus (Palo Alto, CA) CA), 2024-05, Vol.16 (5), p.e60874
Main Authors: Abouzid, Mohamed R, Kamel, Ibrahim, Esteghamati, Sadaf, Mohamed, Kareem, Hamed, Amr
Format: Article
Language:English
Subjects:
Atherosclerosis
Autopsies
Biomechanics
Cardiology
Coronary vessels
Diagnostic tests
Heart attacks
Heart rate
Internal Medicine
Ischemia
Medical imaging
Patients
Physiology
Shear stress
Supply & demand
Therapeutics
Tomography
Ultrasonic imaging
Veins & arteries
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Intramyocardial bridging (IMB) is a congenital anomaly characterized by the tunneling of a coronary artery segment through the myocardium, potentially leading to serious cardiac complications, such as myocardial ischemia, infarction, and sudden death, challenging the traditional view of it being benign. A case involving a 42-year-old man with a seven-day history of atypical chest pain highlights the significance of considering IMB in the differential diagnosis. Despite normal troponin levels, creatine kinase (CK), CK-MB, D-dimer, a negative drug screen, a normal ECG, and chest X-ray and no apparent issues on echocardiogram, left heart catheterization revealed IMB in the left anterior descending artery. This case underscores the necessity of including IMB in the differential diagnosis for chest pain, particularly in young males with familial cardiovascular disease history. While noninvasive imaging methods are useful for diagnosis, coronary angiography is the definitive diagnostic tool. Treatment primarily involves beta-blockers and calcium-channel blockers, with revascularization as a secondary option for those unresponsive to medication.
ISSN:2168-8184
2168-8184
DOI:10.7759/cureus.60874